Immunization With the MAGE-3.A1 Peptide Mixed With the Adjuvant CpG 7909 in Patients With Metastatic Melanoma

This study has been terminated.

( Poor Accrual )

Study NCT00145145 Information provided by Ludwig Institute for Cancer Research

First Received: September 1, 2005 Last Updated: August 21, 2007 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	April 2007
Estimated Primary Completion Date:	No date given